LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial.

    Farnia, Vahid / Tatari, Faeze / Alikhani, Mostafa / Shakeri, Jalal / Taghizadeh, Moshen / Karbasizadeh, Hassan / Sadeghi Bahmani, Dena / Holsboer-Trachsler, Edith / Brand, Serge

    Drug and alcohol dependence

    2017  Volume 176, Page(s) 117–125

    Abstract: Background: Some patients with opioid use disorder (OUD) are treated with methadone maintenance therapy (MMT). However, as with opioids, methadone has major side-effects; sexual dysfunction is a particularly distressing such effect. Rosa Damascena oil ... ...

    Abstract Background: Some patients with opioid use disorder (OUD) are treated with methadone maintenance therapy (MMT). However, as with opioids, methadone has major side-effects; sexual dysfunction is a particularly distressing such effect. Rosa Damascena oil has been shown to reduce subjective sexual dysfunction in patients with major depressive disorders, but its influence on testosterone has not so far been tested. The aim of the present study was to investigate the influence of Rosa Damascena oil on sexual dysfunction and testosterone levels among male patients with OUD and undergoing MMT.
    Methods: A total of 50 male patients (mean age: 40 years) diagnosed with OUD and receiving MMT were randomly assigned either to the Rosa Damascena oil (drops) or a placebo condition. At baseline, and four and eight weeks later, patients completed questionnaires covering sexual and erectile function. Blood samples to assess testosterone levels were taken at baseline and eight weeks later on completion of the study.
    Results: Over time sexual dysfunction decreased, and testosterone increased in the Rosa Damascena oil, but not in the placebo condition. Sexual dysfunction scores and testosterone levels were not consistently related.
    Conclusions: Results from this double-blind, randomized, and placebo-controlled clinical trial showed that Rosa Damascena oil improved sexual function and testosterone levels among males with OUD and undergoing MMT.
    Language English
    Publishing date 2017-07-01
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2017.02.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy - results from a double-blind, randomized, and placebo-controlled trial.

    Farnia, Vahid / Tatari, Faeze / Alikhani, Mostafa / Yazdchi, Katayoun / Taghizadeh, Moshen / Sadeghi Bahmani, Dena / Karbasizadeh, Hassan / Holsboer-Trachsler, Edith / Brand, Serge

    Journal of psychiatric research

    2017  Volume 95, Page(s) 260–268

    Abstract: Background: Methadone maintenance therapy (MMT) is provided to patients with opioid use disorder (OUD). However, as with all opioids, methadone impacts negatively on sexual function. To counter this, Rosa Damascena oil (RDO) has been used successfully ... ...

    Abstract Background: Methadone maintenance therapy (MMT) is provided to patients with opioid use disorder (OUD). However, as with all opioids, methadone impacts negatively on sexual function. To counter this, Rosa Damascena oil (RDO) has been used successfully for opioid-dependent male patients under MMT and with methadone-related sexual dysfunction (MRSD). In the present study, we tested the possible influence of RDO on sexual function and sex hormones of opioid-dependent female patients undergoing MMT and with MRSD.
    Methods: Fifty female patients (mean age: 38.8 years) diagnosed with OUD, undergoing MMT and with MRSD were randomly assigned either to the RDO or the placebo condition. At baseline, patients completed questionnaires covering socio-demographic and OUD-related information. At baseline, and four and eight weeks later they additionally completed questionnaires on sexual function and happiness. Blood samples to assess thyroid hormones, prolactin, progesterone, and estradiol levels were taken at baseline and eight weeks later (end of the study).
    Results: Over time sexual function and happiness increased, but more so in the RDO condition than in the placebo condition. Over time, prolactin decreased, and progesterone, and estradiol increased, but again more so in the RDO condition. Sex hormone levels and sexual function were statistically unrelated.
    Conclusions: Results from this double-blind, randomized, and placebo-controlled clinical trial showed that opioid-dependent females undergoing MMT and with MRDS did benefit from RDO administration, as sexual function and happiness increased, and female sexual hormone levels changed in positive directions.
    MeSH term(s) Adult ; Analgesics, Opioid/adverse effects ; Double-Blind Method ; Female ; Gonadal Steroid Hormones/metabolism ; Happiness ; Humans ; Methadone/adverse effects ; Middle Aged ; Opiate Substitution Treatment/adverse effects ; Opioid-Related Disorders/drug therapy ; Outcome Assessment (Health Care) ; Plant Oils/administration & dosage ; Plant Oils/pharmacology ; Prolactin/drug effects ; Rosa ; Sexual Dysfunction, Physiological/chemically induced ; Sexual Dysfunction, Physiological/drug therapy
    Chemical Substances Analgesics, Opioid ; Gonadal Steroid Hormones ; Plant Oils ; Prolactin (9002-62-4) ; Methadone (UC6VBE7V1Z)
    Language English
    Publishing date 2017-08-16
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 3148-3
    ISSN 1879-1379 ; 0022-3956
    ISSN (online) 1879-1379
    ISSN 0022-3956
    DOI 10.1016/j.jpsychires.2017.08.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top